Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd (SHA:600721)

SHA:600721 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	126.14	272.05	202.07	135.73	86.88	45.62
Trading Asset Securities	127.7	-	-	-	-	10
Cash & Short-Term Investments	253.84	272.05	202.07	135.73	86.88	55.62
Cash Growth	7.10%	34.63%	48.88%	56.22%	56.22%	-42.14%
Accounts Receivable	222.37	202.04	217.65	204.24	167.04	174.17
Other Receivables	4.32	6.45	6.18	3.95	7.94	9.95
Receivables	226.69	208.48	223.82	208.19	174.98	184.12
Inventory	86.22	99.72	124.83	149.43	194.05	188.37
Other Current Assets	7.38	3.02	14.04	12.32	12.18	12.36
Total Current Assets	574.13	583.27	564.77	505.67	468.09	440.46
Property, Plant & Equipment	143.71	140.11	138.19	147.8	161.64	181.89
Long-Term Investments	65.65	63.77	63.7	60.74	58.51	61.7
Goodwill	11.49	11.49	11.49	11.49	11.49	11.49
Other Intangible Assets	7.57	8.41	10.07	11.49	11.67	12.46
Long-Term Deferred Tax Assets	31.05	31.78	14.82	15.4	14.94	15.49
Long-Term Deferred Charges	37.14	30.19	13.47	4.17	4.68	3.83
Other Long-Term Assets	245.83	245.53	245.51	244.93	251.29	247.37
Total Assets	1,117	1,115	1,062	1,002	982.31	974.68
Accounts Payable	86.57	86.65	100.73	92.82	58.39	49.96
Accrued Expenses	24.58	29.57	29.15	26.8	25.18	23.04
Short-Term Debt	-	-	-	-	6.3	-
Current Portion of Leases	-	0.1	0.44	0.51	-	-
Current Income Taxes Payable	-	1.78	1.45	1.22	1.17	1.91
Current Unearned Revenue	126.45	140.51	111.27	98.85	85.73	94.75
Other Current Liabilities	45.79	50.51	65.4	69	77.11	138.57
Total Current Liabilities	283.39	309.12	308.44	289.2	253.89	308.24
Long-Term Leases	-	-	1.13	1.82	-	-
Long-Term Unearned Revenue	0.97	1.06	1.81	2.35	3.02	3.79
Long-Term Deferred Tax Liabilities	44.58	43.52	42.09	39.8	36.88	34.25
Other Long-Term Liabilities	1.1	1.1	1.1	0.5	1.39	3.2
Total Liabilities	331.19	355.96	355.39	334.66	296.06	350.52
Common Stock	384.29	384.03	381.69	377.67	375.13	375.13
Additional Paid-In Capital	2,267	2,266	2,258	2,235	2,217	2,214
Retained Earnings	-1,873	-1,898	-1,940	-1,953	-1,918	-1,978
Comprehensive Income & Other	7.2	7.2	7.29	7.43	7.66	7.85
Total Common Equity	785.37	758.58	706.62	667.01	681.3	619.26
Minority Interest	-	-	-	-	4.95	4.9
Shareholders' Equity	785.37	758.58	706.62	667.01	686.25	624.16
Total Liabilities & Equity	1,117	1,115	1,062	1,002	982.31	974.68
Total Debt	-	0.1	1.57	2.33	6.3	-
Net Cash (Debt)	253.84	271.95	200.5	133.4	80.59	55.62
Net Cash Growth	7.35%	35.64%	50.29%	65.54%	44.90%	-26.94%
Net Cash Per Share	0.66	0.71	0.53	0.35	0.21	0.14
Filing Date Shares Outstanding	385.01	384.03	381.69	377.67	375.13	375.13
Total Common Shares Outstanding	385.01	384.03	381.69	377.67	375.13	375.13
Working Capital	290.74	274.15	256.33	216.47	214.21	132.22
Book Value Per Share	2.04	1.98	1.85	1.77	1.82	1.65
Tangible Book Value	766.32	738.68	685.06	644.04	658.14	595.31
Tangible Book Value Per Share	1.99	1.92	1.79	1.71	1.75	1.59
Buildings	-	161.92	161.92	161.73	158.52	158.52
Machinery	-	174.08	158.62	150.41	146.97	143.87

Source: S&P Global Market Intelligence. Standard template. Financial Sources.